Maha Hussain
- Oncology top 2%
- PARP inhibition in cancer therapy 5
-
- Prostate Cancer Treatment and Research 7
- Cancer Research top 5%
- Molecular Biology top 10%
- Cell death mechanisms and regulation 3
- DNA Repair Mechanisms 2
- Epigenetics and DNA Methylation 2
-
- BRCA gene mutations in cancer 2
-
- Bladder and Urothelial Cancer Treatments 2
-
- Microtubule and mitosis dynamics 2
Maha Hussain
18 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 562
- Molecular Biology 942
- Radiology, Nuclear Medicine and Imaging 232
Countries citing papers authored by Maha Hussain
This map shows the geographic impact of Maha Hussain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Hussain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Hussain more than expected).
Fields of papers citing papers by Maha Hussain
This network shows the impact of papers produced by Maha Hussain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Hussain. The network helps show where Maha Hussain may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maha Hussain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 11 | |
| 4 | 2022 | 23 | |
| 5 | 2021 | 1 | |
| 6 | Olaparib for Metastatic Castration-Resistant Prostate Cancerbreakdown → | 2020 | 1397 |
| 7 | Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancerbreakdown → | 2020 | 474 |
| 8 | 2015 | 10 | |
| 9 | 2015 | 7 | |
| 10 | 2012 | 13 | |
| 11 | 2009 | 113 | |
| 12 | Vorinostat in Advanced Prostate Cancer Patients Progressing on Prior Chemotherapy (National Cancer | 2009 | 1 |
| 13 | 2006 | 29 | |
| 14 | 2005 | 3 | |
| 15 | 2005 | 50 | |
| 16 | 2004 | 48 | |
| 17 | 2004 | 4 | |
| 18 | 2004 | 4 | |
| 19 | 2003 | 69 | |
| 20 | 1996 | 5 |
About Maha Hussain
Maha Hussain is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 20 papers that have together received 2.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), PARP inhibition in cancer therapy (5 papers), Cell death mechanisms and regulation (3 papers), DNA Repair Mechanisms (2 papers), BRCA gene mutations in cancer (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cancer Research (562 citations). Maha Hussain has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Fred Saad, Shahneen Sandhu, David Olmos, Joaquı́n Mateo, Neal D. Shore, Przemyslaw Twardowski, Oliver Sartor, Kim N., Jinyu Kang and Antoine Thiery-Vuillemin. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.